SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biodoc who wrote (5191)8/11/1998 1:46:00 PM
From: Dauntless   of 7041
 
Biodoc - I agree

You wrote:

"No one can know what the Vasomax package insert will contain at this time"

But in your previous post you tried to connect contraindications in the Regitine package with nitrates - implying that Vasomax would have the same limitations. There's too many people on this thread that try to stretch EVERY bit of news or even rumor into a negative about Zonagen or Vasomax. If you are an M.D. I would hope that you'd wait for ALL the information to be presented before expressing your opinion.

You also wrote:

"This label issue is minor compared to the uncertainty surrounding acceptance of the application and ultimate approval. "

See my prior post about percentages of approvals for drugs having completed phase 3 testing. I like the odds.

BTW, can you look up the efficacy of proscar and/or tagamet vs placebo in your PDR and let us know what the numbers are?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext